Asset Planning Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.9M Sell
13,230
-261
-2% -$267K 10.27% 1
2026
Q1
$12.4M Sell
13,491
-16
-0.1% -$16.2K 8.82% 2
2025
Q4
$14.5M Sell
13,507
-292
-2% -$279K 10.2% 2
2025
Q3
$10.5M Sell
13,799
-183
-1% -$136K 7.62% 3
2025
Q2
$10.9M Sell
13,982
-48
-0.3% -$37.3K 8.21% 3
2025
Q1
$11.6M Sell
14,030
-241
-2% -$201K 9.09% 3
2024
Q4
$11M Buy
+14,271
New +$11.8M 8.39% 3

Other funds holding LLY

Asset Planning Inc's LLY Position: Q2 2026 in Review

Asset Planning Inc reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $267K and leaving 13,230 shares worth $15.9M. The position accounts for 10.27% of the portfolio, ranked #1.

Asset Planning Inc first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Asset Planning Inc held 13,230 shares of Eli Lilly worth $15.9M as of Q2 2026.
  • Asset Planning Inc sold 261 Eli Lilly shares in Q2 2026, an estimated $267K.
  • Eli Lilly made up 10.27% of Asset Planning Inc's portfolio in Q2 2026, its #1 holding.
  • Asset Planning Inc first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Asset Planning Inc's 13F filing for Q2 2026, filed 27 Jul 2026.